Geron (GERN) Net Shares Issued and Repurchased (2012 - 2024)
Geron's (GERN) quarterly Net Shares Issued and Repurchased came in at $29.6 million in Q4 2024, up 41.95% year-over-year from $20.9 million in Q1 2024, and up 41.95% quarter-over-quarter from $20.9 million in Q4 2023.
Analysis
Geron (GERN) Net Shares Issued and Repurchased (2012 - 2024) Analysis & Trends
Geron has disclosed Net Shares Issued and Repurchased across 13 years of filings, most recently posting $29.6 million for Q4 2024.
- In Q4 2024, Net Shares Issued and Repurchased rose 41.95% year-over-year to $29.6 million; the TTM figure through Dec 2024 stood at $29.6 million (up 41.95% YoY), while the FY2024 annual figure was $29.6 million, up 41.95% from the prior year.
- Net Shares Issued and Repurchased came in at $29.6 million for Q4 2024 at Geron, up from $20.9 million in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $29.6 million in Q4 2024 to a low of $6.5 million in Q4 2020.
- Average Net Shares Issued and Repurchased over 5 years is $17.3 million, with a median of $19.7 million recorded in 2022.
- Year-over-year, Net Shares Issued and Repurchased tumbled 44.34% in 2020 and soared 106.52% in 2022.
- Over 5 years, Net Shares Issued and Repurchased stood at $6.5 million in 2020, then jumped by 46.39% to $9.6 million in 2021, then jumped by 106.52% to $19.7 million in 2022, then climbed by 5.61% to $20.9 million in 2023, then surged by 41.95% to $29.6 million in 2024.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $29.6 million in Q4 2024, $20.9 million in Q4 2023, and $19.7 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 29.60 Mn |
| Dec 31, 2023 | 20.86 Mn |
| Dec 31, 2022 | 19.75 Mn |
| Dec 31, 2021 | 9.56 Mn |
| Dec 31, 2020 | 6.53 Mn |
| Dec 31, 2019 | 11.74 Mn |
| Mar 31, 2019 | 1.98 Mn |
| Dec 31, 2018 | 9.27 Mn |
| Dec 31, 2017 | 3.48 Mn |
| Dec 31, 2016 | 2.83 Mn |
| Dec 31, 2015 | 2.88 Mn |
| Dec 31, 2014 | 5.66 Mn |
| Dec 31, 2013 | 6.64 Mn |
| Dec 31, 2012 | 7.53 Mn |